USP22 deubiquitinates and enhances the stability of PPARγ protein, thereby promoting the synthesis of FASN, ACLY, and ACACA, and facilitating the malignant progression of hepatocellular carcinoma. The gene discussed is ACLY; the disease is hepatocellular carcinoma.